Alcon Laboratories, Inc.
🇺🇸United States
Clinical Trials
5
Active:5
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
38
FDA:27
NMPA:11
Drug Approvals
Dextran and Hypromellose Eye Drops
- Product Name
- 倍然
- Approval Number
- 国药准字HJ20160565
- Approval Date
- Jan 13, 2025
NMPA
Hypromellose 2910,Dextran 70 and Glycerol Eye Drops
- Product Name
- 新泪然
- Approval Number
- 国药准字HJ20140263
- Approval Date
- Jul 19, 2023
NMPA
Hypromellose 2910, Dextran 70 and Glycerol Eye Drops
- Product Name
- 新泪然
- Approval Number
- 国药准字HJ20140264
- Approval Date
- Jul 19, 2023
NMPA
Fluorescein Sodium Injection
- Product Name
- 历设得
- Approval Number
- 国药准字HJ20130649
- Approval Date
- Jul 11, 2023
NMPA
Balance Salt Solution Irrigating
- Product Name
- 平衡盐溶液(供灌注用)
- Approval Number
- 国药准字HJ20171363
- Approval Date
- Oct 14, 2022
NMPA
Balanced Salt Solution Irrigating
- Product Name
- 平衡盐溶液(供灌注用)
- Approval Number
- 国药准字HJ20171364
- Approval Date
- Oct 14, 2022
NMPA
Polyethylene Glycol Eye Drops
- Product Name
- 思然
- Approval Number
- 国药准字HJ20160105
- Approval Date
- Dec 3, 2020
NMPA
Dextran and Hypromellose Eye Drops
- Product Name
- 倍然
- Approval Number
- H20160565
- Approval Date
- May 14, 2020
NMPA
Hypromellose 2910, Dextran 70 and Glycerol Eye Drops
- Product Name
- 新泪然
- Approval Number
- H20140264
- Approval Date
- Jan 3, 2020
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)No trials found
News
No news found